Warning! GuruFocus detected
1 Severe warning sign
with OGEN.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Oragenics Inc
NAICS : 325412
SIC : 2834
ISIN : US6840233026
Description
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.63 | |||||
| Equity-to-Asset | -0.14 | |||||
| Debt-to-Equity | -1.55 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 41.8 | |||||
| 3-Year EPS without NRI Growth Rate | 41.8 | |||||
| 3-Year FCF Growth Rate | 42.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 44.38 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 14.93 | |||||
| 9-Day RSI | 17.7 | |||||
| 14-Day RSI | 23.48 | |||||
| 3-1 Month Momentum % | -21.72 | |||||
| 6-1 Month Momentum % | -35.74 | |||||
| 12-1 Month Momentum % | -77.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.87 | |||||
| Quick Ratio | 0.87 | |||||
| Cash Ratio | 0.51 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -86.4 | |||||
| Shareholder Yield % | -164.66 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -529.19 | |||||
| ROA % | -295.41 | |||||
| ROIC % | -917.45 | |||||
| 3-Year ROIIC % | -702.56 | |||||
| ROC (Joel Greenblatt) % | -1734.65 | |||||
| ROCE % | -527.64 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.33 | |||||
| EV-to-EBITDA | -0.33 | |||||
| EV-to-FCF | -0.41 | |||||
| Earnings Yield (Greenblatt) % | -303.03 | |||||
| FCF Yield % | -213.86 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:OGEN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Oragenics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.856 | ||
| Beta | 1.42 | ||
| 3-Year Sharpe Ratio | -0.84 | ||
| 3-Year Sortino Ratio | -1.07 | ||
| Volatility % | 143.13 | ||
| 14-Day RSI | 23.48 | ||
| 14-Day ATR ($) | 0.02267 | ||
| 20-Day SMA ($) | 0.24734 | ||
| 12-1 Month Momentum % | -77.13 | ||
| 52-Week Range ($) | 0.177 - 3.43 | ||
| Shares Outstanding (Mil) | 21.48 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Oragenics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Oragenics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Oragenics Inc Frequently Asked Questions
What is Oragenics Inc(OGEN)'s stock price today?
The current price of OGEN is $0.19. The 52 week high of OGEN is $3.43 and 52 week low is $0.18.
When is next earnings date of Oragenics Inc(OGEN)?
The next earnings date of Oragenics Inc(OGEN) is 2025-05-15 Est..
Does Oragenics Inc(OGEN) pay dividends? If so, how much?
Oragenics Inc(OGEN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers